21st Century Oncology Holdings, Inc.
Healthcare · Services-Offices & Clinics of Doctors of Medicine · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | −$16.7M | −$30.8M | −$87.8M | −$154.2M | −$353.4M | −$113.8M |
| Total assets | $1.16B | $1.15B | $1.13B | $922.3M | $998.6M | $1.24B |
| Total liabilities | $1.28B | $1.26B | $1.19B | $892.5M | $808.6M | $720.8M |
| Equity | −$530.0M | −$493.4M | −$93.8M | $2.4M | $159.9M | $497.0M |
| EPS (diluted) | — | — | $-78181.29 | $-150446.83 | $-346171.40 | — |
| Shares out. | 1,028 | 1,028 | 1,025 | 1,025 | 1,025 | 1,000 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- —
- Return on equity
- 3.1%
- Return on assets
- −1.4%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 110.0%
- Debt / equity
- —
- Book value / share
- $-515571.01
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Accruals / assets
- −3.4%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Other material eventMay 25, 2017
- Entered a material agreement · New financial obligationMar 9, 2017
- Director / officer changeMar 1, 2017
- Entered a material agreementFeb 2, 2017
- Director / officer changeJan 26, 2017
- Entered a material agreementJan 17, 2017
- Entered a material agreementDec 16, 2016
- Entered a material agreement · New financial obligationDec 7, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.